Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             47 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Actigraphic and patient and family reported sleep outcomes in children and youth with cystic fibrosis: A systematic review McMurray, Jordana

21 2 p. e49-e82
artikel
2 Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis Cameron, LH

21 2 p. 348-352
artikel
3 Advanced but not mild liver disease is a predictor of decreased survival in children with cystic fibrosis, with far greater impact in females: A 27-year real-life cohort study Baldissera, Marilisa

21 2 p. 230-235
artikel
4 A new path for CF clinical trials through the use of historical controls Magaret, Amalia S.

21 2 p. 293-299
artikel
5 A new perspective on opportunistic pathogens of the genus Bordetella in cystic fibrosis Menetrey, Quentin

21 2 p. 344-347
artikel
6 Aquagenic wrinkling of the palms in cystic fibrosis patients treated with ivacaftor Jacobi, Eyal

21 2 p. e102-e105
artikel
7 Arm muscle area for the longitudinal assessment of nutritional status in paediatric patients with cystic fibrosis - A single centre experience Ellemunter, Helmut

21 2 p. e122-e128
artikel
8 A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021 Barr, H.L.

21 2 p. 191-196
artikel
9 Barriers implementing infection prevention and control experienced by healthcare workers, people with CF and parents Saiman, Lisa

21 2 p. 309-315
artikel
10 Clinical presentation and basic defect of the CFTR genotype p.Phe508del / p.Arg117His in a mother and her monozygous twin daughters Lex, Christiane

21 2 p. 375-377
artikel
11 Defining and Treating Cystic Fibrosis Liver Disease: Some Things Old and Some Things New Galante, Gary J.

21 2 p. 199-201
artikel
12 Drug-induced liver injury from elexacaftor/ivacaftor/tezacaftor Lowry, Sarah

21 2 p. e99-e101
artikel
13 Editorial Board
21 2 p. ii
artikel
14 Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis Petersen, Max C.

21 2 p. 265-271
artikel
15 Exercise intolerance in cystic fibrosis-the role of CFTR modulator therapies Caterini, Jessica E.

21 2 p. 282-292
artikel
16 Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype Aalbers, B.L.

21 2 p. 254-257
artikel
17 From the Editor's Desk Flume, Patrick A.

21 2 p. 197-198
artikel
18 Functional Restoration of CFTR Nonsense Mutations in Intestinal Organoids de Poel, E.

21 2 p. 246-253
artikel
19 Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis Calvopina, Diego A.

21 2 p. 236-242
artikel
20 Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study Archangelidi, Olga

21 2 p. 302-308
artikel
21 Indoor air pollution exposure is associated with greater morbidity in cystic fibrosis Carson, Sara W.

21 2 p. e129-e135
artikel
22 Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR Drummond, David

21 2 p. 212-219
artikel
23 Macrophages from gut-corrected CF mice express human CFTR and lack a pro-inflammatory phenotype Gillan, Jonathan L

21 2 p. 370-374
artikel
24 Magnetic resonance imaging of cystic fibrosis: Multi-organ imaging in the age of CFTR modulator therapies McBennett, Kimberly

21 2 p. e148-e157
artikel
25 Management of Cystic Fibrosis during COVID-19: Patient Reported Outcomes based remote follow-up among CF patients in Denmark – A feasibility study Rodkjær, Lotte

21 2 p. e106-e112
artikel
26 Mental status changes during elexacaftor/tezacaftor / ivacaftor therapy Heo, Suyeon

21 2 p. 339-343
artikel
27 News article
21 2 p. 189-190
artikel
28 Olfactory dysfunction in cystic fibrosis: Impact of CFTR modulator therapy Beswick, Daniel M.

21 2 p. e141-e147
artikel
29 Pilot RCT of a telehealth intervention to reduce symptoms of depression and anxiety in adults with cystic fibrosis Bathgate, Christina J.

21 2 p. 332-338
artikel
30 Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis Furstova, Eva

21 2 p. 243-245
artikel
31 Restoration of exocrine pancreatic function in child with lumacaftor/ivacaftor therapy in cystic fibrosis Crowley, J.

21 2 p. 264
artikel
32 Rethinking physical exercise training in the modern era of cystic fibrosis: A step towards optimising short-term efficacy and long-term engagement Gruet, Mathieu

21 2 p. e83-e98
artikel
33 SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy Alicandro, Gianfranco

21 2 p. e113-e116
artikel
34 Serological biomarkers for the diagnosis of Mycobacterium abscessus infections in cystic fibrosis patients Le Moigne, Vincent

21 2 p. 353-360
artikel
35 Structural lung disease in preschool children with cystic fibrosis: An 18 month natural history study Brody, Alan S.

21 2 p. e165-e171
artikel
36 The effectiveness of exercise interventions to increase physical activity in Cystic Fibrosis: A systematic review Curran, M.

21 2 p. 272-281
artikel
37 The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis Scully, Kevin J.

21 2 p. 258-263
artikel
38 The impact of cystic fibrosis on the working life of patients: A systematic review Leso, Veruscka

21 2 p. 361-369
artikel
39 The impact of liver disease on mortality in cystic fibrosis–A systematic review Sasame, Ao

21 2 p. 202-211
artikel
40 TLR5 signalling is hyper-responsive in porcine cystic fibrosis airways epithelium Fleurot, Isabelle

21 2 p. e117-e121
artikel
41 Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor? Granger, Emily

21 2 p. 316-322
artikel
42 Unexpected associations between respiratory viruses and bacteria with Pulmonary Function Testing in children suffering from Cystic Fibrosis (MUCOVIB study) Scherz, Valentin

21 2 p. e158-e164
artikel
43 Urinary sodium/creatinine ratio is a predictor for fractional sodium excretion and related to age in patients with cystic fibrosis Declercq, Dimitri

21 2 p. e136-e140
artikel
44 Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study Colombo, Carla

21 2 p. 220-226
artikel
45 Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis McKinzie, Cameron J.

21 2 p. 227-229
artikel
46 Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis Bevan, Amanda

21 2 p. 323-331
artikel
47 Working in partnership with the patient community to develop outline trial designs in CF Rowbotham, NJ

21 2 p. 300-301
artikel
                             47 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland